Apr 3, 2009 - Taro Pharmaceutical Industries Ltd. today reported that it received final approval from the U.S. FDA for its Abbreviated New Drug Application for Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg and 400 mg.
The details can be read here.
No comments:
Post a Comment